| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.27▼ | 1.29▼ | 1.29▼ | 1.35▼ | 1.49▼ |
| MA10 | 1.32▼ | 1.34▼ | 1.35▼ | 1.35▼ | 1.67▼ |
| MA20 | 1.36▼ | 1.36▼ | 1.35▼ | 1.47▼ | 1.72▼ |
| MA50 | 1.41▼ | 1.46▼ | 1.49▼ | 1.70▼ | 2.05▼ |
| MA100 | 1.55▼ | 1.61▼ | 1.66▼ | 1.71▼ | 3.60▼ |
| MA200 | 1.73▼ | 1.68▼ | 1.75▼ | 1.89▼ | 3.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.007▼ | -0.004▼ | -0.001▼ | -0.021▼ |
| RSI | 35.287▼ | 35.751▼ | 34.817▼ | 34.887▼ | 38.617▼ |
| STOCH | 1.190▼ | 0.980▼ | 4.314▼ | 31.151 | 24.503 |
| WILL %R | -95.238▼ | -95.238▼ | -95.238▼ | -100.000▼ | -97.340▼ |
| CCI | -85.490 | -115.040▼ | -119.041▼ | -132.989▼ | -111.721▼ |
|
Friday, November 14, 2025 02:25 PM
An update from CASI Pharmaceuticals ( ($CASI) ) is now available. On November 14, 2025, CASI Pharmaceuticals announced its third-quarter 2025 ...
|
|
Friday, November 14, 2025 02:04 PM
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...
|
|
Monday, November 10, 2025 02:27 PM
An announcement from CASI Pharmaceuticals ( ($CASI) ) is now available. CASI Pharmaceuticals announced that it received a delisting determination ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.3324 | 1.35 | 1.26 | 1.26 | 20,592 |
| 13/11/25 | 1.42 | 1.4799 | 1.32 | 1.335 | 17,236 |
| 12/11/25 | 1.37 | 1.48 | 1.37 | 1.45 | 17,784 |
| 11/11/25 | 1.34 | 1.45 | 1.31 | 1.38 | 25,100 |
| 10/11/25 | 1.40 | 1.41 | 1.30 | 1.34 | 26,637 |
| 07/11/25 | 1.35 | 1.4512 | 1.28 | 1.38 | 33,412 |
| 06/11/25 | 1.38 | 1.47 | 1.30 | 1.33 | 11,574 |
| 05/11/25 | 1.31 | 1.37 | 1.31 | 1.35 | 21,015 |
| 04/11/25 | 1.40 | 1.40 | 1.30 | 1.33 | 20,082 |
| 03/11/25 | 1.46 | 1.46 | 1.37 | 1.39 | 18,031 |
|
|
||||
|
|
||||
|
|